» Articles » PMID: 35991694

Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology Settings

Overview
Journal Kidney Med
Specialty Nephrology
Date 2022 Aug 22
PMID 35991694
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease is a public health problem that has generated renewed interest due to poor patient outcomes and high cost. The Advancing American Kidney Health initiative aimed to transform kidney care with goals of decreasing the incidence of kidney failure and increasing the number of patients receiving home dialysis or a kidney transplant. New value-based models of kidney care that specify inclusion of pharmacists as part of the kidney care team were developed to help achieve these goals. To support this Advancing American Kidney Health-catalyzed opportunity for pharmacist engagement, the pharmacy workforce must have a fundamental knowledge of the core principles needed to provide comprehensive medication management to address chronic kidney disease and the common comorbid conditions and secondary complications. The Advancing Kidney Health through Optimal Medication Management initiative was created by nephrology pharmacists with the vision that every person with kidney disease receives optimal medication management through team-based care that includes a pharmacist to ensure medications are safe, effective, and convenient. Here, we propose education standards for pharmacists providing care for individuals with kidney disease in the outpatient setting to complement proposed practice standards.

Citing Articles

Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis.

Wang V, Wang C, Assimon M, Pun P, Winkelmayer W, Flythe J JAMA Netw Open. 2024; 7(4):e248732.

PMID: 38687480 PMC: 11061769. DOI: 10.1001/jamanetworkopen.2024.8732.


Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes.

Neumiller J, St Peter W, Shubrook J J Clin Med. 2024; 13(5).

PMID: 38592214 PMC: 10932148. DOI: 10.3390/jcm13051367.


Community pharmacists' perspectives on assessing kidney function and medication dosing for patients with advanced chronic kidney disease: A qualitative study using the theoretical domains framework.

Tran J, Shaffelburg C, Phelan E, Neville H, Lively A, Poyah P Can Pharm J (Ott). 2024; 156(5):272-281.

PMID: 38222892 PMC: 10786017. DOI: 10.1177/17151635231176530.


Pharmacy Practice Standards for Outpatient Nephrology Settings.

Cardone K, Maxson R, Cho K, Davis J, El Nekidy W, Kane-Gill S Kidney Med. 2022; 4(8):100509.

PMID: 35991693 PMC: 9386099. DOI: 10.1016/j.xkme.2022.100509.

References
1.
Alruqayb W, Price M, Paudyal V, Cox A . Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review. Drug Saf. 2021; 44(10):1041-1058. DOI: 10.1007/s40264-021-01099-3. View

2.
Hall R, Blumenthal J, Doerfler R, Chen J, Diamantidis C, Jaar B . Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021; 78(6):837-845.e1. PMC: 8608689. DOI: 10.1053/j.ajkd.2021.03.019. View

3.
Yang H, Li L, Hu X, Wang W, Yang X, Liu H . Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: A retrospective pre- and post-intervention study. J Clin Pharm Ther. 2019; 44(4):603-610. DOI: 10.1111/jcpt.12826. View

4.
Inker L, Eneanya N, Coresh J, Tighiouart H, Wang D, Sang Y . New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021; 385(19):1737-1749. PMC: 8822996. DOI: 10.1056/NEJMoa2102953. View

5.
Manley H, Aweh G, Weiner D, Jiang H, Miskulin D, Johnson D . Multidisciplinary Medication Therapy Management and Hospital Readmission in Patients Undergoing Maintenance Dialysis: A Retrospective Cohort Study. Am J Kidney Dis. 2020; 76(1):13-21. DOI: 10.1053/j.ajkd.2019.12.002. View